Cipla Limited has informed the Exchange about press release dated 07-Sep-2022 titled Cipla receives USFDA approval for the generic version of Revlimid�� (Lenalidomide capsules)
Cipla Limited has informed the Exchange about press release dated 07-Sep-2022 titled Cipla receives USFDA approval for the generic version of Revlimid�� (Lenalidomide capsules)